Literature DB >> 13992947

Failure of dexamethasone suppression test to indicate bilateral adrenocortical hyperplasia in Cushing's syndrome.

S R SILVERMAN, R T MARNELL, L J SHOLITON, E E WERK.   

Abstract

Entities:  

Keywords:  ADRENAL CORTEX HORMONES; ADRENAL CORTEX HYPERFUNCTION; CUSHING'S SYNDROME; DEXAMETHASONE

Mesh：

Substances：

Year:  1963        PMID： 13992947     DOI： 10.1210/jcem-23-2-167

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  6 in total

1.  Variation in response to dexamethasone of a patient with Cushing's syndrome.

Authors:  O Rorstad; R Urtasun; M Watanabe
Journal:  Can Med Assoc J       Date:  1976-11-06       Impact factor: 8.262

Review 2.  [Ectopic paraneoplastic endocrinopathies associated with water-electrolyte balance disorders].

Authors:  K Hayduk; W Kaufmann
Journal:  Klin Wochenschr       Date:  1973-04-15

3.  Cushing's syndrome with nodular adrenal hyperplasia.

Authors:  H S Tucker; H L Estep; D M Hume; M Vinik; S Kay
Journal:  Trans Am Clin Climatol Assoc       Date:  1969

4.  [10. Surgery of the adrenal gland. (Pathological report)].

Authors:  G Dhom
Journal:  Langenbecks Arch Chir       Date:  1967

5.  [The diagnosis and differential diagnosis of Cushing's syndrome by means of an abbreviated dexamethasone test in the determination of corticosteroids in plasma].

Authors:  H Bethge; M T Brauns; H G Solbach; W Winkelmann; H Zimmermann
Journal:  Klin Wochenschr       Date:  1966-08-01

6.  Efficacy of dexamethasone suppression test during the diagnosis of primary pigmented nodular adrenocortical disease in Chinese adrenocorticotropic hormone-independent Cushing syndrome.

Authors:  Shi Chen; Ran Li; Lin Lu; Lian Duan; Xuebin Zhang; Anli Tong; Hui Pan; Huijuan Zhu; Zhaolin Lu
Journal:  Endocrine       Date:  2017-11-01       Impact factor: 3.633
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.